172
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents: in vitro and in silico approach

, , , , , ORCID Icon, , & show all
Pages 1191-1207 | Received 02 Feb 2023, Accepted 28 Mar 2023, Published online: 30 May 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Munendra Kumar, Parveen, Nafis Raj, Shabana Khatoon, Khalid Umar Fakhri, Prateek Kumar, Mubarak A. Alamri, Mehnaz Kamal, Nikhat Manzoor, Harsha, Renu Solanki, Gehan M. Elossaily, Yahya I. Asiri, Mohd. Zaheen Hassan & Monisha Khanna Kapur. (2024) In-silico and in-vitro evaluation of antifungal bioactive compounds from Streptomyces sp. strain 130 against Aspergillus flavus. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now
Kumari Swati, Sudhir Rama Varma, R. P. Parameswari, Siva Prasad Panda, Mohit Agrawal, Anand Prakash, Dhruv Kumar & Prasoon Agarwal. Computational exploration of FOXM1 inhibitors for glioblastoma: an integrated virtual screening and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now
Dilip C. Kanjariya, Hem N. Naik, Meet J. Sherashiya, Yogesh T. Naliapara, Iqrar Ahmad, Harun Patel, Dhanji Rajani & Smita Jauhari. α-Amylase and mycobacterium-TB H37Rv antagonistic efficacy of novel pyrazole-coumarin hybrids: an in vitro and in silico investigation. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-18.
Read now

Articles from other publishers (1)

Fahad Alhawday, Fahad Alminderej, Siwar Ghannay, Bechir Hammami, Abuzar E. A. E. Albadri, Adel Kadri & Kaiss Aouadi. (2024) In Silico Design, Synthesis, and Evaluation of Novel Enantiopure Isoxazolidines as Promising Dual Inhibitors of α-Amylase and α-Glucosidase. Molecules 29:2, pages 305.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.